# CIPROFLOXACIN AND DEXAMETHASONE
> **ANDA216487** · Abbreviated New Drug Application (Generic) · Sponsor: UPSHER SMITH LABS · Approved 2026-01-06
## Drug
- **FDA Application Number:** ANDA216487
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CIPROFLOXACIN AND DEXAMETHASONE
- **Generic name:** CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE
- **Active ingredients:** CIPROFLOXACIN; DEXAMETHASONE
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OTIC
- **Marketing status:** Prescription
- **Sponsor:** UPSHER SMITH LABS
- **Manufacturer:** Upsher-Smith Laboratories, LLC
- **First approval:** 2026-01-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216487)
---
*AI Analytics · CC0 1.0*